Free Trial
→ 3..2..1.. AI 2.0 ignition (don’t sleep on this) (From Timothy Sykes) (Ad) Free NBY Stock Alerts

NovaBay Pharmaceuticals (NBY) SEC Filings & 10K Form

NovaBay Pharmaceuticals logo
$0.67 -0.02 (-3.18%)
As of 03:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent NovaBay Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
06/04/2025
11:46 AM		NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D
04/15/2025
11:40 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:46 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:50 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:11 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:18 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:22 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:30 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:30 PM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:33 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEF 14A
03/11/2025
3:35 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:07 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:08 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
02/06/2025
5:30 PM		NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:58 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:58 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
01/23/2025
7:12 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
01/23/2025
7:13 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:27 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:06 PM		NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
01/10/2025
6:03 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
6:00 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:12 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
12/09/2024
6:05 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/26/2024
3:08 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/22/2024
3:27 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:10 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/13/2024
4:15 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/12/2024
3:52 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/08/2024
4:31 PM		Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G/A
11/06/2024
3:46 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:15 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:19 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
10/16/2024
3:27 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:19 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFM14A
09/25/2024
4:17 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form PREM14A
09/20/2024
7:08 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:08 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
07/29/2024
3:25 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
6:18 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 424B4
07/26/2024
4:19 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form POS EX
A new rule goes live in July — and the banks are quietly cashing in (Ad)

A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.

To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how
07/25/2024
11:15 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
07/24/2024
7:49 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSEAMERICAN:NBY) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Hedge fund legend humiliates Bitcoin traders
Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...
Brownstone Research | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
An extra $1,000 per month?
A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...
TradeSmith | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsored
Trump’s biggest move, misreported
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...
Porter & Company | Sponsored